Geneva-Popova, M., Popova, S. Study of serum Osteoprotegerin and Receptor activator of nuclear factor Kappa-B Ligand in patients with rheumatic diseases. Pleven: 2021 4170-4177,.
Geneva-Popova, M., Popova, S. Study of serum Osteoprotegerin and Receptor activator of nuclear factor Kappa-B Ligand in patients with rheumatic diseases. Pleven: 2021 4170-4177,.
Geneva-Popova, M., Popova, S. (2021) Study of serum Osteoprotegerin and Receptor activator of nuclear factor Kappa-B Ligand in patients with rheumatic diseases, Pleven: 4170-4177,.
Geneva-Popova, M., & Popova, S. (2021). Study of serum Osteoprotegerin and Receptor activator of nuclear factor Kappa-B Ligand in patients with rheumatic diseases. Pleven: 4170-4177.
Geneva-Popova M, Popova S. Study of serum Osteoprotegerin and Receptor activator of nuclear factor Kappa-B Ligand in patients with rheumatic diseases. Pleven: 2021. p. 4170-4177.